• I’m Channeling My Grief About ALS into Action and Advocacy
  • Neos Completes Dosing in Phase 1 Trial of Anti-Drooling Treatment NT0502 in Healthy Volunteers
  • Alexion to Initiate Phase 3 Trial of Ultomiris for Familiar, Sporadic ALS Patients
  • A New Paradigm for the Future of ALS
  • ALS Research Ambassador Collaboration Enabled More Patient-centered Design of REFINE-ALS Trial
  • AstroRx Increases Ability to Perform Daily Functions in ALS Patients, Trial Results Show
  • Kadimastem Finishes Treating Second Group of ALS Patients with AstroRx in Phase 1/2a Trial
  • Learning the Rules for the Medicare Guessing Game
  • Mitochondrial ‘Suicide’ May Signal Start of Neurodegeneration in ALS, Mouse Study Suggests
  • Insurance Data May Predict ALS, Research Shows
  • Join Our Virtual Friendly Neighborhood, the ALS News Today Forums
  • END ALS Association Founder Lights Up Room With Holiday Spirit to Raise Disease Awareness